What pharma news happened in July 2019?

82 regulatory actions across global regulators, 0 Phase 3 trial completions, and 0 patent expiries — all sourced from primary regulatory + USPTO + ClinicalTrials.gov.

How fresh is this archive?

Each month's archive solidifies as it passes — the current month updates every 30 minutes; past months are stable historical archives.

July 2019 — Pharma News Archive

Every regulatory action (82), Phase 3 readout (0), and patent expiry (0) tracked in July 2019. Sourced from Drugs@FDA, EMA EPAR, ClinicalTrials.gov, USPTO Orange Book.

82 regulatory actions 0 Phase 3 readouts 0 patent expiries

Regulatory actions (82)

2019-07-31 — Colcrys · FDA · approved · US · Scilex Pharms · Immunology
2019-07-30 — Nubeqa · FDA · approved · US · Bayer · Oncology
2019-07-30 — Muscle relaxant therapy · FDA · approved · US · Second Affiliated Hospital, School of Medicine, Zhejiang University · Musculoskeletal/Pain Management
2019-07-30 — Nubeqa · FDA · approved · US · Bayer · Oncology
2019-07-29 — Piperacillin And Tazobactam · FDA · approved · US · Pfizer · Infectious Disease
2019-07-25 — trientine dihydrochloride · EMA · approved · EU · Univar BV · Metabolic/Genetic Disorders
2019-07-25 — Syprine · EMA · approved · EU · Bausch Health · Oncology
2019-07-25 — SCH 56592 · EMA · approved · EU · Merck Sharp & Dohme LLC
2019-07-25 — SCH 56592 · EMA · approved · EU · Merck Sharp & Dohme LLC
2019-07-25 — R-Gene 10 · EMA · approved · EU · Pfizer · Metabolic
2019-07-25 — L-Lysine · EMA · approved · EU · Advanced Accelerator Applications · Metabolic
2019-07-25 — Lotrimin · FDA · approved · US · Bayer AG · Infectious Disease
2019-07-25 — ABT-335 · FDA · approved · US · AstraZeneca · Cardiovascular
2019-07-25 — arginine/lysine · EMA · approved · EU · Advanced Accelerator Applications · Immunology
2019-07-24 — Glucagon Nasal Powder [Baqsimi] · FDA · approved · US · Eli Lilly and Company
2019-07-24 — Intranasal glugagon · FDA · approved · US · A.O.U. Città della Salute e della Scienza · Metabolic
2019-07-24 — Mycostatin · FDA · approved · US · Generic (originally Squibb) · Infectious Disease
2019-07-24 — Nystatin 100.000 units · FDA · approved · US · University of Sao Paulo
2019-07-23 — Slynd · FDA · approved · US · Exeltis Usa Inc · Dermatology
2019-07-23 — HADLIMA · FDA · approved · US · SAMSUNG BIOEPIS CO LTD · Other
2019-07-22 — Fanapt · FDA · approved · US · Vanda Pharms Inc · Metabolic
2019-07-22 — Rozerem · FDA · approved · US · Takeda · Metabolic
2019-07-21 — Merrem · FDA · approved · US · Pfizer · Metabolic
2019-07-19 — Lyrica · FDA · approved · US · Pfizer Inc. · Metabolic
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-19 — paracetamol + pregabalin + dexamethasone · FDA · approved · US · Glostrup University Hospital, Copenhagen · Pain Management, Neurology
2019-07-18 — Zinc gluconate supplement · FDA · approved · US · University of Florida · Nutrition
2019-07-18 — Zinc Sulfate · FDA · approved · US · Am Regent · Immunology
2019-07-18 — Benicar · FDA · approved · US · Cosette · Metabolic
2019-07-18 — Losartan, Losartan and HCTZ, Amlodipine , Spironolactone · FDA · approved · US · Biomedis International Ltd.
2019-07-17 — Cyklokapron · FDA · approved · US · Pfizer Inc. · Rare Disease
2019-07-17 — Cyklokapron · FDA · approved · US · Exela Pharma · Cardiovascular
2019-07-16 — Cosmegen · FDA · approved · US · Recordati · Oncology
2019-07-16 — Recarbrio · FDA · approved · US · Merck & Co. · Infectious Disease
2019-07-16 — Imipenem/Cilastatin/Relebactam · FDA · approved · US · Evopoint Biosciences Inc. · Infectious Disease
2019-07-15 — Firazyr · FDA · approved · US · Sebastian Videla · Neuroscience
2019-07-15 — ICATIBANT ACETATE · FDA · approved · US
2019-07-12 — Technescan Mag3 · FDA · approved · US · Curium · Nephrology
2019-07-12 — Edecrin · FDA · approved · US · Bausch Health · Immunology
2019-07-12 — Lymphazurin · FDA · approved · US · Other
2019-07-10 — Antiepileptic drug therapy · FDA · approved · US · University College, London
2019-07-10 — Sandimmune · FDA · approved · US · Novartis · Oncology
2019-07-10 — Onfi · FDA · approved · US · Lundbeck Pharms Llc · Neuroscience
2019-07-10 — OMEGA-3-ACID ETHYL ESTERS · FDA · approved · US
2019-07-10 — Icosapent · FDA · approved · US · National Institute on Alcohol Abuse and Alcoholism (NIAAA) · Metabolic
2019-07-10 — Abiraterone Acetate · FDA · approved · US · Janssen Biotech · Oncology
2019-07-10 — CYCLOSPORINE · FDA · approved · US
2019-07-09 — CHLORPHENIRAMINE · FDA · approved · US · Respiratory
2019-07-09 — Risedronate · FDA · approved · US · Toronto Rehabilitation Institute · Bone
2019-07-09 — Actonel® · FDA · approved · US · Amgen
2019-07-08 — AMLODIPINE BENZOATE · FDA · approved · US
2019-07-08 — Differin · FDA · approved · US · Galderma Labs Lp · Metabolic
2019-07-08 — Talzenna · EMA · approved · EU · Pfizer Inc. · Oncology
2019-07-05 — ABT-335 · FDA · approved · US · AstraZeneca · Cardiovascular
2019-07-05 — Ranexa · FDA · approved · US · Menarini Intl · Metabolic
2019-07-05 — Ranexa · FDA · approved · US · Midwest Cardiovascular Research Foundation · Other
2019-07-03 — TRIENTINE HYDROCHLORIDE · FDA · approved · US
2019-07-02 — Lozanoc · FDA · approved · US · Mayne Pharma International Pty Ltd · Other
2019-07-02 — ALXN1210 SC · EMA · approved · EU · Alexion Pharmaceuticals, Inc.
2019-07-02 — Hemabate · FDA · approved · US · Pfizer · Other
2019-07-02 — Medical Management · FDA · approved · US · CVRx, Inc.
2019-07-02 — Bismuth quadruple therapy · FDA · approved · US · Zhongda Hospital · Infectious Disease
2019-07-02 — Metro I.V. In Plastic Container · FDA · approved · US · Baxter · Immunology
2019-07-01 — Actos · FDA · approved · US · Takeda · Metabolic
2019-07-01 — Ketorolac at high dose · FDA · approved · US · Tianjin Medical University General Hospital
2019-07-01 — Xromi · EMA · approved · EU · Nova Laboratories Limited · Oncology
2019-07-01 — Uloric · FDA · approved · US · Takeda · Immunology
2019-07-01 — Dolutegravir/Lamivudine · EMA · approved · EU · Saint Michael's Medical Center · Infectious Disease / Virology
2019-07-01 — cardiac output changes with "phenylephrine" · FDA · approved · US · University Tunis El Manar · Cardiovascular
2019-07-01 — Haloperidol Injection · FDA · approved · US · Hennepin Healthcare Research Institute · Psychiatry
2019-07-01 — Haldol · FDA · approved · US · Michelle Weckmann · Other
2019-07-01 — HGP1405 · FDA · approved · US · Hanmi Pharmaceutical Company Limited
2019-07-01 — Uloric · FDA · approved · US · Takeda · Immunology

Phase 3 trial readouts (0)

No Phase 3 readouts tracked in this month.

Patent expiries (0)

No patent expiries tracked in this month.

Subscribe to ongoing alerts

This page is a permanent monthly archive. For ongoing alerts as new events happen:

July 2019 — Pharma News Archive

Regulatory actions (82)

Phase 3 trial readouts (0)

Patent expiries (0)

Subscribe to ongoing alerts

See also